Second, p185HER2/neu could phosphorylate and activate major signalling pathways such as phosphatidylinositol-3-kinase (PI3K/Akt) and mitogen-activated protein kinase (MAPK) pathways and promote cell survival, tumor growth and metastasis [10,17,18]. This evidence concerns the gene ERBB2 and neoplasm.